S&P 500   3,314.32 (-0.22%)
DOW   29,081.25 (-0.36%)
QQQ   223.85 (-0.01%)
GOOGL   1,486.63 (+0.17%)
AMZN   1,881.49 (-0.32%)
CGC   24.39 (+1.12%)
NVDA   252.17 (+0.85%)
BABA   218.22 (-1.87%)
MU   59.16 (-0.02%)
GE   11.72 (+3.08%)
TSLA   564.95 (-0.81%)
AMD   51.28 (-0.29%)
T   38.62 (-1.08%)
ACB   2.04 (+0.00%)
NFLX   342.77 (+5.14%)
BAC   34.03 (-0.99%)
DIS   141.66 (-1.63%)
GILD   63.16 (-0.43%)
S&P 500   3,314.32 (-0.22%)
DOW   29,081.25 (-0.36%)
QQQ   223.85 (-0.01%)
GOOGL   1,486.63 (+0.17%)
AMZN   1,881.49 (-0.32%)
CGC   24.39 (+1.12%)
NVDA   252.17 (+0.85%)
BABA   218.22 (-1.87%)
MU   59.16 (-0.02%)
GE   11.72 (+3.08%)
TSLA   564.95 (-0.81%)
AMD   51.28 (-0.29%)
T   38.62 (-1.08%)
ACB   2.04 (+0.00%)
NFLX   342.77 (+5.14%)
BAC   34.03 (-0.99%)
DIS   141.66 (-1.63%)
GILD   63.16 (-0.43%)
S&P 500   3,314.32 (-0.22%)
DOW   29,081.25 (-0.36%)
QQQ   223.85 (-0.01%)
GOOGL   1,486.63 (+0.17%)
AMZN   1,881.49 (-0.32%)
CGC   24.39 (+1.12%)
NVDA   252.17 (+0.85%)
BABA   218.22 (-1.87%)
MU   59.16 (-0.02%)
GE   11.72 (+3.08%)
TSLA   564.95 (-0.81%)
AMD   51.28 (-0.29%)
T   38.62 (-1.08%)
ACB   2.04 (+0.00%)
NFLX   342.77 (+5.14%)
BAC   34.03 (-0.99%)
DIS   141.66 (-1.63%)
GILD   63.16 (-0.43%)
S&P 500   3,314.32 (-0.22%)
DOW   29,081.25 (-0.36%)
QQQ   223.85 (-0.01%)
GOOGL   1,486.63 (+0.17%)
AMZN   1,881.49 (-0.32%)
CGC   24.39 (+1.12%)
NVDA   252.17 (+0.85%)
BABA   218.22 (-1.87%)
MU   59.16 (-0.02%)
GE   11.72 (+3.08%)
TSLA   564.95 (-0.81%)
AMD   51.28 (-0.29%)
T   38.62 (-1.08%)
ACB   2.04 (+0.00%)
NFLX   342.77 (+5.14%)
BAC   34.03 (-0.99%)
DIS   141.66 (-1.63%)
GILD   63.16 (-0.43%)
Log in
(Ad)
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

NYSE:BAX - Baxter International Stock Price, Forecast & News

$91.24
+0.08 (+0.09 %)
(As of 01/23/2020 01:36 PM ET)
Today's Range
$90.53
Now: $91.24
$91.43
50-Day Range
$81.66
MA: $85.23
$91.16
52-Week Range
$68.69
Now: $91.24
$91.86
Volume764,035 shs
Average Volume2.41 million shs
Market Capitalization$46.58 billion
P/E Ratio30.72
Dividend Yield0.97%
Beta0.98
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.62 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$46.58 billion
Next Earnings Date1/30/2020 (Estimated)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, November 19th. Shareholders of record on Friday, December 6th will be paid a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Thursday, December 5th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International announced that its board has initiated a stock buyback program on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) posted its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. The firm's quarterly revenue was up 2.2% compared to the same quarter last year. During the same period last year, the business earned $0.64 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Baxter International.

What price target have analysts set for BAX?

15 equities research analysts have issued 12 month price targets for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they anticipate Baxter International's stock price to reach $93.15 in the next year. This suggests a possible upside of 2.3% from the stock's current price. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

Headlines about BAX stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Baxter International.

Are investors shorting Baxter International?

Baxter International saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 4,300,000 shares, a decrease of 18.4% from the November 28th total of 5,270,000 shares. Based on an average daily trading volume, of 2,860,000 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.8% of the shares of the stock are short sold. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), BlackRock (BLK), Johnson & Johnson (JNJ), Verizon Communications (VZ), Honeywell International (HON), Alibaba Group (BABA), Home Depot (HD), Procter & Gamble (PG) and AT&T (T).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of of institutional and retail investors. Top institutional investors include SPF Beheer BV (0.20%), Calamos Advisors LLC (0.19%), Marathon Asset Management LLP (0.17%), Huntington National Bank (0.10%), PGGM Investments (0.09%) and Gateway Investment Advisers LLC (0.06%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Bangor Savings Bank, United Services Automobile Association, Janney Montgomery Scott LLC, Gateway Investment Advisers LLC, CENTRAL TRUST Co and Calamos Advisors LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, Marathon Asset Management LLP, Benson Investment Management Company Inc., SPF Beheer BV, Nisa Investment Advisors LLC, FormulaFolio Investments LLC, Huntington National Bank and DNB Asset Management AS. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $91.09.

How big of a company is Baxter International?

Baxter International has a market capitalization of $46.51 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  649 (Vote Outperform)
Underperform Votes:  569 (Vote Underperform)
Total Votes:  1,218
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel